Patiromer for the management of hyperkalaemia in patients receiving renin-angiotensin-aldosterone system inhibitors for heart failure: design and rationale of the DIAMOND trial.
- DOI
- 10.1002/ejhf.2386
- Published
- 2022 Jan
- Container
- European journal of heart failure
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1002/ejhf.2386,
title = {Patiromer for the management of hyperkalaemia in patients receiving renin-angiotensin-aldosterone system inhibitors for heart failure: design and rationale of the DIAMOND trial.},
author = {Butler J and Anker SD and Siddiqi TJ and Coats AJS and Dorigotti F and Filippatos G and Friede T and Göhring UM and Kosiborod MN and Lund LH and Metra M and Moreno Quinn C and Piña IL and Pinto FJ and Rossignol P and Szecsödy P and Van Der Meer P and Weir M and Pitt B},
year = {2022},
journal = {European journal of heart failure},
doi = {10.1002/ejhf.2386},
url = {https://doi.org/10.1002/ejhf.2386}
}RIS
TY - JOUR TI - Patiromer for the management of hyperkalaemia in patients receiving renin-angiotensin-aldosterone system inhibitors for heart failure: design and rationale of the DIAMOND trial. AU - Butler J AU - Anker SD AU - Siddiqi TJ AU - Coats AJS AU - Dorigotti F AU - Filippatos G AU - Friede T AU - Göhring UM AU - Kosiborod MN AU - Lund LH AU - Metra M AU - Moreno Quinn C AU - Piña IL AU - Pinto FJ AU - Rossignol P AU - Szecsödy P AU - Van Der Meer P AU - Weir M AU - Pitt B PY - 2022 JO - European journal of heart failure DO - 10.1002/ejhf.2386 UR - https://doi.org/10.1002/ejhf.2386 ER -
APA
J, B., SD, A., TJ, S., AJS, C., F, D., G, F., T, F., UM, G., MN, K., LH, L., M, M., C, M. Q., IL, P., FJ, P., P, R., P, S., P, V. D. M., M, W., & B, P. (2022). Patiromer for the management of hyperkalaemia in patients receiving renin-angiotensin-aldosterone system inhibitors for heart failure: design and rationale of the DIAMOND trial.. European journal of heart failure. https://doi.org/10.1002/ejhf.2386
Source records
- pubmed · retrieved 2026-09-25T16:30:06.587Z